Conceptional design of an adjustable moderator for BNCT based on a neutron source of 2.8 MeV proton bombarding with Li target
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Beam shaping assembly (BSA) is a vital component in Boron Neutron Capture Therapy (BNCT) for obtaining epithermal neutron beams. Several feasible designs of BSA for accelerator-based BNCT (AB-BNCT) neutron source are carried out based on neutrons by bombarding a natural lithium target with 10 mA, 2.8 MeV proton beams. The calculation results demonstrate that a thickness of 45 cm is appropriate for general moderators referring to the therapeutic parameter of Advanced Depth (AD). A series of optimizations are performed and two results are confirmed: One is that employing the configuration of MgF2 and FLUENTAL combined by 1:1 could improve the therapeutic rate (TR) of tumors at a depth of middle region, and the other one is that the TR of superficial tumors can be increased by adding a 5 cm thick boron-11 secondary moderator at the end of general moderators. As a result, an innovative conception of an adjustable moderator is recommended to BNCT. Compared to the MgF2 moderator with a fixed thickness of 45 cm, the TR value can be improved by a maximum of 47.7 % by using the adjustable moderator. Furthermore, the configuration of adjustable moderator has been designed with regulation method for treating tumors of different depths.
Abstract
Beam shaping assembly (BSA) is a vital component in Boron Neutron Capture Therapy (BNCT) for obtaining epithermal neutron beams. Several feasible designs of BSA for accelerator-based BNCT (AB-BNCT) neutron source are carried out based on neutrons by bombarding a natural lithium target with 10 mA, 2.8 MeV proton beams. The calculation results demonstrate that a thickness of 45 cm is appropriate for general moderators referring to the therapeutic parameter of Advanced Depth (AD). A series of optimizations are performed and two results are confirmed: One is that employing the configuration of MgF2 and FLUENTAL combined by 1:1 could improve the therapeutic rate (TR) of tumors at a depth of middle region, and the other one is that the TR of superficial tumors can be increased by adding a 5 cm thick boron-11 secondary moderator at the end of general moderators. As a result, an innovative conception of an adjustable moderator is recommended to BNCT. Compared to the MgF2 moderator with a fixed thickness of 45 cm, the TR value can be improved by a maximum of 47.7 % by using the adjustable moderator. Furthermore, the configuration of adjustable moderator has been designed with regulation method for treating tumors of different depths.
참고문헌 (23)
- G. L. Locher, "Biological effects and therapeutic possibilities of neutrons", Am. J. Roentgenol. Radium Ther, 36, pp.1~13 (1936)
- Ryo Ogawara, "Polyethylene moderator optimized for increasing thermal neutron flux in the NASBEE accelerator-based neutron field", Radiat. Meas (2020)[DOI]
- Huifang He, "The basis and advances in clinical application of boron neutron capture therapy", Radiat. Oncol, 16, pp.216~ (2021)[DOI]
- Saverio Altieri, "A brief review on reactor-based neutron sources for boron neutron capture therapy", Therapeut. Radiol. Oncol (2018)[DOI]
- B. A. Ludewigt, "Clinical requirements and accelerator concepts for BNCT", Particle Accelerator Conference. Proceedings of the 1997 IEEE (1997)
- Yong-Shun Tian, "Design of beam shaping assembly based on 3.5 MeV radio-frequency quardrupole proton accelerator for boron neutron capture therapy", Acta Phys. Sin (2018)[DOI]
- Takahiro Kato, "Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center", Appl. Radiat. Isot (2020)[DOI]
- Pablo Torres-Sanchez, "Optimized beam shaping assembly for a 2.1 MeV proton-accelerator-based neutron source for boron neutron capture therapy", Sci. Rep (2021)[DOI]
- Joshua P. Sroka, "Design of a moderator assembly delimiter for an ABNS for BNCT", American Nuclear Society Topical Meeting, 2005 (2005)
- Current Status of Neutron Capture Therapy, "IAEA", ~, pp.IAEA-TECDOC-1223 (2001)
- Guangru Li, "Design of beam shaping assemblies for accelerator-based BNCT with multi- terminals", Front. Public Health (2021)[DOI]
- D. A. Allen, "A design study for an accelerator-based epithermal neutron beam for BNCT", Phys. Med. Biol (1994)
- Heikki Joensuu, "Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine", J. Neuro Oncol (2003)[DOI]
- Y. Kasesaz, "Optimization of the beam shaping assembly in the D-D neutron generators-based BNCT using the response matrix method", Appl. Radiat. Isot (2013)[DOI]
- Photon, Electron, Proton and Neutron Interaction Data for Body Tissues, "ICRU", ~, pp.ICRU REPORT, vol. 46 (1992)
- Tissue Substitutes in Radiation Dosimetry and Measurement, "ICRU", ~, pp.ICRU REPORT 44 (1989)
- O. E. Kononov, "Optimization of an accelerator-based epithermal neutron source for neutron capture therapy", The 11th World Congress on Neutron Capture Therapy (ISNCT-11), 2004 (2004)
- Jingli Liu Kiger, "Functional and histological changes in rat lung after boron neutron capture therapy", Radiat. Res. Soc (2008)[DOI]
- Li Deng, "Diagnostic Techniques and Surgical Management of Brian Tumors" (2001)
- Shintaro Ishiyama, "Determination of the compound biological effectiveness (CBE) factors based on the ISHIYAMAIMAHORI deterministic parsing model with the dynamic PET technique", J. Cancer Ther (2015)[DOI]
- Minoru Suzuki, "Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer", J. Radiat. Res (2014)[DOI]
- Itsuro Kato, "Effectiveness of BNCT for recurrent head and neck malignancies", Appl. Radiat. Isot (2004)[DOI]
- Lilia Zaidi, "Monte Carlo based dosimetry for neutron capture therapy of brain tumors", EPJ Web Conf, 128, pp.04003~ (2016)[DOI]